Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18783627 | USE OF MTNAC33 GENE AND AN ENCODED PROTEIN THEREBY IN IMPROVING THE BIOMASS AND DROUGHT TOLERANCE OF MEDICAGO SATIVA L. | July 2024 | December 2024 | Allow | 5 | 1 | 0 | No | No |
| 18155210 | TBRFV RESISTANT TOMATO PLANT | January 2023 | April 2025 | Allow | 26 | 0 | 0 | No | No |
| 18072683 | Plants and Seeds of Corn Variety CV553006 | November 2022 | March 2025 | Allow | 28 | 1 | 0 | No | No |
| 17979734 | SOYBEAN VARIETY 01093524 | November 2022 | January 2025 | Allow | 26 | 1 | 0 | No | No |
| 17974059 | RICE CULTIVAR 'AROMA 22' | October 2022 | April 2025 | Allow | 30 | 1 | 0 | No | No |
| 17995648 | METHOD FOR PRODUCING AVENANTHRAMIDE-RICH OATS USING ACTIVE ELICITORS | October 2022 | May 2025 | Allow | 31 | 3 | 0 | No | No |
| 17954827 | SOYBEAN CULTIVAR 13380227 | September 2022 | January 2025 | Allow | 28 | 1 | 0 | No | No |
| 17954769 | SOYBEAN CULTIVAR 12070855 | September 2022 | January 2025 | Allow | 28 | 1 | 0 | No | No |
| 17951343 | SOYBEAN CULTIVAR 19390713 | September 2022 | January 2025 | Allow | 28 | 1 | 0 | No | No |
| 17951327 | SOYBEAN CULTIVAR 10170604 | September 2022 | November 2024 | Allow | 26 | 1 | 0 | No | No |
| 17949680 | SOYBEAN CULTIVAR 13323023 | September 2022 | January 2025 | Allow | 28 | 1 | 0 | No | No |
| 17949590 | SOYBEAN CULTIVAR 12350011 | September 2022 | January 2025 | Allow | 28 | 1 | 0 | No | No |
| 17946378 | SOYBEAN CULTIVAR 17230739 | September 2022 | November 2024 | Allow | 26 | 1 | 0 | No | No |
| 17932430 | CANOLA INBRED 4PQEY54A | September 2022 | March 2025 | Allow | 30 | 2 | 0 | No | No |
| 17932519 | CANOLA INBRED 4PYYM82A | September 2022 | April 2025 | Allow | 31 | 1 | 0 | No | No |
| 17943899 | SOYBEAN CULTIVAR 18330107 | September 2022 | October 2024 | Allow | 25 | 1 | 0 | No | No |
| 17941636 | SOYBEAN CULTIVAR 16030115 | September 2022 | November 2024 | Allow | 26 | 1 | 0 | No | No |
| 17939738 | SOYBEAN CULTIVAR 16450023 | September 2022 | August 2024 | Allow | 23 | 1 | 0 | No | No |
| 17939911 | PEPPER HYBRID SVPS9064 AND PARENTS THEREOF | September 2022 | September 2024 | Allow | 24 | 1 | 0 | No | No |
| 17891812 | PEPPER HYBRID SVPB9514 AND PARENTS THEREOF | August 2022 | September 2024 | Allow | 25 | 1 | 0 | No | No |
| 17808581 | MAIZE HYBRID X13V198 | June 2022 | January 2025 | Allow | 31 | 1 | 0 | Yes | No |
| 17807628 | MAIZE INBRED 1PMSZ41 | June 2022 | March 2025 | Allow | 33 | 2 | 0 | No | No |
| 17807562 | MAIZE INBRED 1PLRC84 | June 2022 | March 2025 | Allow | 33 | 3 | 0 | No | No |
| 17807591 | MAIZE INBRED 1PWFK43 | June 2022 | January 2025 | Allow | 31 | 1 | 0 | No | No |
| 17807415 | MAIZE INBRED 1PWDE32 | June 2022 | January 2025 | Allow | 31 | 2 | 0 | No | No |
| 17831509 | STSCI PROTEIN FOR CHANGING SELF-INCOMPATIBILITY OF DIPLOID POTATO MATERIALS | June 2022 | May 2025 | Allow | 36 | 2 | 0 | Yes | No |
| 17779355 | ROP - DEFICIENT PLANTS HAVING HIGH WATER USE EFFICIENCY | May 2022 | December 2024 | Allow | 30 | 1 | 0 | Yes | No |
| 17729926 | INBRED RICE LINE DG263L | April 2022 | June 2024 | Allow | 26 | 1 | 0 | Yes | No |
| 17723806 | BARLEY MALE STERILITY GENE HVMSG47 AND USE THEREOF | April 2022 | June 2024 | Allow | 26 | 2 | 0 | Yes | No |
| 17754973 | GENOMIC ALTERATION OF PLANT GERMLINE | April 2022 | April 2025 | Allow | 36 | 1 | 1 | No | No |
| 17641791 | TOMATO PLANTS HAVING FRUIT WITH HIGH ZEAXANTHIN CONTENT | March 2022 | November 2024 | Abandon | 32 | 0 | 1 | No | No |
| 17564650 | WHEAT CULTIVAR 01095217 | December 2021 | March 2024 | Allow | 27 | 1 | 0 | No | No |
| 17617027 | COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS | December 2021 | April 2024 | Abandon | 28 | 1 | 1 | No | No |
| 17616276 | CONTROL OF SPODOPTERA | December 2021 | June 2024 | Allow | 30 | 2 | 0 | Yes | No |
| 17457138 | Engineering, production and characterization of plant produced Nucleocapsid and Spike structural proteins of SARS CoV 2 as vaccine candidates against COVID19 | December 2021 | August 2024 | Abandon | 32 | 0 | 1 | No | No |
| 17528375 | RECOMBINANT LAC POLYNUCLEOTIDES AND USES THEREOF TO INCREASE PRODUCTION OF C-LIGNIN IN PLANTS | November 2021 | December 2023 | Allow | 25 | 2 | 0 | No | No |
| 17528520 | Plants and Seeds of Hybrid Corn Variety CH011203 | November 2021 | February 2024 | Allow | 27 | 1 | 0 | No | No |
| 17595447 | ABIOTIC STRESS TOLERANT PLANTS AND METHODS | November 2021 | January 2024 | Allow | 26 | 1 | 1 | No | No |
| 17595442 | ABIOTIC STRESS TOLERANT PLANTS AND METHODS | November 2021 | January 2024 | Allow | 26 | 1 | 1 | No | No |
| 17454315 | PLANT DERIVED INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE | November 2021 | November 2024 | Abandon | 36 | 1 | 1 | No | No |
| 17510525 | Plants and Seeds of Hybrid Corn Variety CH011160 | October 2021 | February 2024 | Allow | 27 | 1 | 0 | No | No |
| 17451913 | LEGHEMOGLOBIN IN SOYBEAN | October 2021 | June 2023 | Abandon | 20 | 1 | 0 | No | No |
| 17507445 | Plants and Seeds of Corn Variety CV381120 | October 2021 | April 2024 | Allow | 30 | 1 | 0 | No | No |
| 17506337 | Plants and Seeds of Hybrid Corn Variety CH011231 | October 2021 | April 2024 | Allow | 30 | 1 | 0 | No | No |
| 17594475 | MODIFIED PLANTS COMPRISING A POLYNUCLEOTIDE COMPRISING A NON-COGNATE PROMOTER OPERABLY LINKED TO A CODING SEQUENCE THAT ENCODES A TRANSCRIPTION FACTOR | October 2021 | August 2024 | Allow | 34 | 2 | 0 | No | No |
| 17499864 | Rice thermo-sensitive male sterile gene mutant tms18 and uses thereof | October 2021 | July 2023 | Allow | 21 | 1 | 0 | No | No |
| 17601579 | STEVIA PLANT HAVING LESS ABILITY TO FORM FLOWER BUDS | October 2021 | February 2025 | Allow | 41 | 1 | 1 | No | No |
| 17442179 | LOW-METHANE RICE | September 2021 | April 2025 | Abandon | 42 | 3 | 1 | No | No |
| 17441509 | Modulation of Transgene Expression | September 2021 | December 2023 | Abandon | 27 | 1 | 1 | No | No |
| 17437973 | PESTICIDAL GENES AND METHODS OF USE | September 2021 | November 2024 | Allow | 38 | 3 | 1 | Yes | No |
| 17437259 | Expression of Nitrogenase Polypeptides In Plant Cells | September 2021 | May 2025 | Allow | 44 | 2 | 1 | No | No |
| 17458916 | GRAIN PRODUCTION WITH MALE-STERILE FEMALE PLANTS | August 2021 | August 2023 | Allow | 24 | 1 | 0 | No | No |
| 17432264 | ENGINEERED PESTICIDAL PROTEINS AND METHODS OF CONTROLLING PLANT PESTS | August 2021 | July 2024 | Allow | 35 | 1 | 1 | No | No |
| 17429674 | GENE FOR RESISTANCE TO PLANT DISEASE | August 2021 | May 2024 | Allow | 33 | 2 | 1 | No | No |
| 17429176 | NEW GENE RESPONSIBLE FOR CYTOPLASMIC MALE STERILITY | August 2021 | October 2024 | Allow | 38 | 2 | 1 | Yes | Yes |
| 17392841 | OSNF-YA5 GENE FROM ORYZA SATIVA FOR INCREASING NITROGEN AVAILABILITY OF PLANT AND USES THEREOF | August 2021 | April 2023 | Allow | 20 | 1 | 0 | No | No |
| 17427570 | METHOD FOR IMPROVING RICE YIELD AND/OR RICE BLAST RESISTANCE AND PROTEIN USED THEREOF | July 2021 | March 2023 | Allow | 20 | 1 | 0 | No | No |
| 17417982 | LOW-TYRAMINE STEVIA PLANT | June 2021 | April 2025 | Abandon | 45 | 1 | 1 | No | No |
| 17336525 | Pleiotropic Gene that Increases Biomass and Sugar Yield in Sorghum and Sugarcane | June 2021 | February 2025 | Abandon | 45 | 3 | 0 | No | No |
| 17289335 | INSECTICIDAL PROTEINS | April 2021 | February 2024 | Abandon | 33 | 0 | 1 | No | No |
| 17286173 | GENOME EDITING TO INCREASE SEED PROTEIN CONTENT | April 2021 | May 2025 | Abandon | 49 | 2 | 1 | Yes | No |
| 17205889 | Single Nucleotide Polymorphism (SNP) Markers for Stevia | March 2021 | January 2024 | Allow | 34 | 2 | 0 | Yes | No |
| 17200258 | PLANTS COMPRISING WHEAT G-TYPE CYTOPLASMIC MALE STERILITY RESTORER GENES, MOLECULAR MARKERS AND USES THEREOF | March 2021 | April 2025 | Allow | 49 | 2 | 1 | Yes | No |
| 17273159 | GENETICALLY ENGINEERED LAND PLANTS THAT EXPRESS AN INCREASED SEED YIELD PROTEIN AND/OR AN INCREASED SEED YIELD RNA | March 2021 | May 2024 | Allow | 38 | 1 | 1 | No | No |
| 17188144 | GENERATION OF BIOMASS | March 2021 | November 2024 | Abandon | 44 | 1 | 1 | No | No |
| 17180195 | MODIFIED FORM OF OLEOSIN THAT WHEN EXPRESSED IN PLANTS LEADS TO INCREASED TRIACYLGLYCEROL (OIL) ACCUMULATION | February 2021 | May 2025 | Allow | 51 | 3 | 1 | Yes | No |
| 17266730 | MOLECULAR MARKERS FOR BLACKLEG RESISTANCE GENE RLM7 IN BRASSICA NAPUS, AND METHODS OF USING THE SAME | February 2021 | September 2024 | Allow | 43 | 1 | 1 | No | No |
| 17250303 | CANNABIS VARIETY WHICH PRODUCES GREATER THAN 50% FEMALE PLANTS | December 2020 | April 2024 | Allow | 40 | 1 | 1 | Yes | No |
| 17252220 | SEX IDENTIFICATION OF CANNABIS PLANTS | December 2020 | April 2024 | Abandon | 41 | 2 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner RADOSAVLJEVIC, ALEKSANDAR.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 100.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner RADOSAVLJEVIC, ALEKSANDAR works in Art Unit 1662 and has examined 68 patent applications in our dataset. With an allowance rate of 80.9%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 30 months.
Examiner RADOSAVLJEVIC, ALEKSANDAR's allowance rate of 80.9% places them in the 45% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by RADOSAVLJEVIC, ALEKSANDAR receive 1.34 office actions before reaching final disposition. This places the examiner in the 27% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by RADOSAVLJEVIC, ALEKSANDAR is 30 months. This places the examiner in the 39% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +14.1% benefit to allowance rate for applications examined by RADOSAVLJEVIC, ALEKSANDAR. This interview benefit is in the 56% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 50.0% of applications are subsequently allowed. This success rate is in the 97% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 81.8% of cases where such amendments are filed. This entry rate is in the 96% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 85% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 66.7% are granted (fully or in part). This grant rate is in the 82% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.